Company profile TARS
After 39 days of this quarter the interest is at 72.0. Based on that we can calculate that during remaining 52 days it will total up to 168.0. Tarsus Pharmaceuticals expected interest is significantly lower compared to same quarter last year (-56.2%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 15 | 33 120.0% QoQ | 28 -15.2% QoQ | 105 275.0% QoQ |
| 2020 | 21 40.0% YoY -80.0% QoQ | 114 245.5% YoY 442.9% QoQ | 145 417.9% YoY 27.2% QoQ | 163 55.2% YoY 12.4% QoQ |
| 2021 | 120 471.4% YoY -26.4% QoQ | 160 40.4% YoY 33.3% QoQ | 80 -44.8% YoY -50.0% QoQ | 164 0.6% YoY 105.0% QoQ |
| 2022 | 153 27.5% YoY -6.7% QoQ | 135 -15.6% YoY -11.8% QoQ | 108 35.0% YoY -20.0% QoQ | 137 -16.5% YoY 26.9% QoQ |
| 2023 | 384 151.0% YoY 180.3% QoQ | 337 149.6% YoY -12.2% QoQ | 372 244.4% YoY 10.4% QoQ | 232 69.3% YoY -37.6% QoQ |
| 2024 | 72 -81.2% YoY -69.0% QoQ | - | - | - |
The average 5 years interest of Tarsus Pharmaceuticals was 11.79 per week. The last year interest of Tarsus Pharmaceuticals compared to the last 5 years has changed by 108.14%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 532.47%.
There is not enough data for Tarsus Pharmaceuticals TP-03 to provide analysis
There is not enough data for Tarsus Pharmaceuticals TP-03 to provide correlation calculation
There is not enough data for Tarsus Pharmaceuticals TP-03 to provide analysis
There is not enough data for Tarsus Pharmaceuticals TP-04 to provide analysis
There is not enough data for Tarsus Pharmaceuticals TP-04 to provide correlation calculation
There is not enough data for Tarsus Pharmaceuticals TP-04 to provide analysis
There is not enough data for Tarsus Pharmaceuticals TP-05 to provide analysis
There is not enough data for Tarsus Pharmaceuticals TP-05 to provide correlation calculation
There is not enough data for Tarsus Pharmaceuticals TP-05 to provide analysis
There is not enough data for Tarsus Pharmaceuticals lotilaner to provide analysis
There is not enough data for Tarsus Pharmaceuticals lotilaner to provide correlation calculation
There is not enough data for Tarsus Pharmaceuticals lotilaner to provide analysis
There is not enough data for Tarsus Pharmaceuticals blepharitis treatment to provide analysis
There is not enough data for Tarsus Pharmaceuticals blepharitis treatment to provide correlation calculation
There is not enough data for Tarsus Pharmaceuticals blepharitis treatment to provide analysis
There is not enough data for Tarsus Pharmaceuticals meibomian gland disease treatment to provide analysis
There is not enough data for Tarsus Pharmaceuticals meibomian gland disease treatment to provide correlation calculation
There is not enough data for Tarsus Pharmaceuticals meibomian gland disease treatment to provide analysis
There is not enough data for Tarsus Pharmaceuticals rosacea treatment to provide analysis
There is not enough data for Tarsus Pharmaceuticals rosacea treatment to provide correlation calculation
There is not enough data for Tarsus Pharmaceuticals rosacea treatment to provide analysis
Google Trends for Tarsus Pharmaceuticals Lyme prophylaxis
Not enough data for reliable calculations!
There is not enough data for Tarsus Pharmaceuticals Lyme prophylaxis to provide analysis
There is not enough data for Tarsus Pharmaceuticals Lyme prophylaxis to provide correlation calculation
There is not enough data for Tarsus Pharmaceuticals Lyme prophylaxis to provide analysis
There is not enough data for Tarsus Pharmaceuticals community malaria reduction to provide analysis
There is not enough data for Tarsus Pharmaceuticals community malaria reduction to provide correlation calculation
There is not enough data for Tarsus Pharmaceuticals community malaria reduction to provide analysis